Insider Selling: Paysign, Inc. (NASDAQ:PAYS) CEO Sells 25,000 Shares of Stock

Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer sold 25,000 shares of the firm’s stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $3.27, for a total transaction of $81,750.00. Following the sale, the chief executive officer now owns 9,236,886 shares in the company, valued at approximately $30,204,617.22. This trade represents a 0.27 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Mark Newcomer also recently made the following trade(s):

• On Monday, November 18th, Mark Newcomer sold 40,000 shares of Paysign stock. The shares were sold at an average price of $3.24, for a total value of $129,600.00.
• On Wednesday, October 23rd, Mark Newcomer sold 36,000 shares of Paysign stock. The stock was sold at an average price of $3.66, for a total value of $131,760.00.
• On Monday, October 21st, Mark Newcomer sold 22,000 shares of Paysign stock. The stock was sold at an average price of $3.75, for a total value of $82,500.00.
• On Monday, September 23rd, Mark Newcomer sold 50,000 shares of Paysign stock. The shares were sold at an average price of $4.25, for a total transaction of $212,500.00.
• On Thursday, September 19th, Mark Newcomer sold 1,500 shares of Paysign stock. The stock was sold at an average price of $4.50, for a total transaction of $6,750.00.
• On Friday, September 13th, Mark Newcomer sold 1,500 shares of Paysign stock. The shares were sold at an average price of $4.50, for a total value of $6,750.00.

Paysign Price Performance

PAYS opened at $3.39 on Thursday. Paysign, Inc. has a one year low of $2.22 and a one year high of $5.59. The firm has a market capitalization of $181.53 million, a price-to-earnings ratio of 22.60 and a beta of 0.95. The business has a 50 day simple moving average of $3.85 and a two-hundred day simple moving average of $4.29.

Paysign (NASDAQ:PAYS) last posted its earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.02. The business had revenue of $15.26 million for the quarter, compared to analysts’ expectations of $14.96 million. Paysign had a net margin of 14.28% and a return on equity of 30.64%. During the same quarter in the prior year, the business earned $0.02 EPS. As a group, sell-side analysts expect that Paysign, Inc. will post 0.21 EPS for the current fiscal year.

Hedge Funds Weigh In On Paysign

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Joule Financial LLC purchased a new position in shares of Paysign during the third quarter valued at $1,478,000. Renaissance Technologies LLC boosted its position in Paysign by 25.0% in the second quarter. Renaissance Technologies LLC now owns 1,504,380 shares of the company’s stock valued at $6,484,000 after buying an additional 301,000 shares during the last quarter. Royce & Associates LP purchased a new stake in shares of Paysign in the 3rd quarter valued at $814,000. Sanctuary Advisors LLC purchased a new stake in shares of Paysign in the second quarter worth about $512,000. Finally, Vanguard Group Inc. boosted its holdings in Paysign by 3.0% during the first quarter. Vanguard Group Inc. now owns 1,649,043 shares of the company’s stock worth $6,035,000 after buying an additional 48,489 shares in the last quarter. Hedge funds and other institutional investors own 25.89% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Barrington Research reiterated an “outperform” rating and issued a $7.00 price objective on shares of Paysign in a research report on Monday, November 4th.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.